Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(1-trifluoromethyl-cyclopropyl)-phenyl-acetamide
US-11555025-B2 · Jan 17, 2023 · US
This page is not indexed by search engines while we improve data quality.
Heidmann Bibia patents
Heidmann Bibia is listed as an inventor on 31 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Heidmann Bibia |
| Total patents | 31 |
| First publication | Jun 11, 2015 |
| Latest publication | Jan 17, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Crystalline form of n-[1-(5-cyano-pyridin-2-ylmethyl)-1 h-pyrazol-3-yl]-2-[4-(1-trifluo-romethyl-cyclopropyl)-phenyl]-acetamide
US-2021300894-A1 · Sep 30, 2021 · US
Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-acetamide
US-11059803-B2 · Jul 13, 2021 · US
Benzimidazole-proline derivatives
US-11040966-B2 · Jun 22, 2021 · US
Crystalline form of n-[1-(5-cyano-pyridin-2-ylmethyl)-1 h-pyrazol-3-yl]-2-[4-(1-trifluo-romethyl-cyclopropyl)-phenyl]-acetamide
US-2020165221-A1 · May 28, 2020 · US
Benzimidazole-proline derivatives
US-2019263797-A1 · Aug 29, 2019 · US
Benzimidazole-proline derivatives
US-10329287-B2 · Jun 25, 2019 · US
Triazole compounds as T-type calcium channel blockers
US-10246426-B2 · Apr 2, 2019 · US
Pyrazole compounds and their use as T-type calcium channel blockers
US-10065929-B2 · Sep 4, 2018 · US
Triazole compounds as t-type calcium channel blockers
US-2018230109-A1 · Aug 16, 2018 · US
Recent patents
Latest publications not already listed above.
Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-10023560-B2 · Jul 17, 2018 · US
Pyrazole compounds and their use as t-type calcium channel blockers
US-2018105496-A1 · Apr 19, 2018 · US
Pyrazole compounds and their use as T-type calcium channel blockers
US-9932314-B2 · Apr 3, 2018 · US
Use of benzimidazole-proline derivatives
US-9914721-B2 · Mar 13, 2018 · US
Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
US-9914720-B2 · Mar 13, 2018 · US
Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-2018002317-A1 · Jan 4, 2018 · US
Benzimidazole-proline derivatives
US-2017305897-A1 · Oct 26, 2017 · US
Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-9790208-B2 · Oct 17, 2017 · US
Benzimidazole-proline derivatives
US-9732075-B2 · Aug 15, 2017 · US
Pyrazole compounds and their use as t-type calcium channel blockers
US-2017096399-A1 · Apr 6, 2017 · US
Use of benzimidazole-proline derivatives
US-2017001985-A1 · Jan 5, 2017 · US
Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
US-2016368901-A1 · Dec 22, 2016 · US
Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-2016355506-A1 · Dec 8, 2016 · US
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
US-9493446-B2 · Nov 15, 2016 · US
Azetidine amide derivatives as orexin receptor antagonists
US-9403813-B2 · Aug 2, 2016 · US
Pyrazole and imidazole derivatives useful as orexin antagonists
US-9303023-B2 · Apr 5, 2016 · US
Azetidine amide derivatives as orexin receptor antagonists
US-2016024064-A1 · Jan 28, 2016 · US
2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists
US-9150566-B2 · Oct 6, 2015 · US
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
US-2015252032-A1 · Sep 10, 2015 · US
Benzimidazole-proline derivatives
US-2015166527-A1 · Jun 18, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Idorsia Pharmaceuticals Ltd | 18 |
| Actelion Pharmaceuticals Ltd | 15 |
| Bolli Martin | 2 |
| Boss Christoph | 2 |
| Brotschi Christine | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.